Workflow
Safety Shot(SHOT) - 2024 Q4 - Annual Report
SHOTSafety Shot(SHOT)2025-03-28 21:00

Financial Performance - Safety Shot Inc. reported a net loss of 51.7millionfortheyearendedDecember31,2024,comparedtoanetlossof51.7 million for the year ended December 31, 2024, compared to a net loss of 15.1 million for 2023, reflecting an increase in losses of 243%[252] - The Company generated revenues of 701,967fortheyearendedDecember31,2024,comparedto701,967 for the year ended December 31, 2024, compared to 202,670 for the year ended December 31, 2023, reflecting an increase due to the commencement of marketing and selling its Safety Shot beverage in December 2023[267] - Total operating expenses for the year ended December 31, 2024, were 39,611,915,significantlyhigherthan39,611,915, significantly higher than 12,524,869 for the year ended December 31, 2023[268] - The net loss from continuing operations was 48,411,830fortheyearendedDecember31,2024,comparedto48,411,830 for the year ended December 31, 2024, compared to 14,821,513 for the year ended December 31, 2023[266] - The Company had a gross profit (loss) of (2,445,757)fortheyearendedDecember31,2024,comparedto(2,445,757) for the year ended December 31, 2024, compared to (74,457) for the year ended December 31, 2023[266] - Losses from discontinued operations were 997,802fortheyearendedDecember31,2024,comparedto997,802 for the year ended December 31, 2024, compared to 261,528 for the year ended December 31, 2023[273] - Other income for the year ended December 31, 2024, included realized gains of 1,193,666onthesaleofmarketablesecurities[271]TheCompanyincurredadeemeddividendof1,193,666 on the sale of marketable securities[271] - The Company incurred a deemed dividend of 2,293,301 related to the settlement with Bigger Capital, which is considered in the determination of earnings per share[275] Product Development and Strategy - The company launched its e-commerce sales of the Safety Shot Beverage in December 2023, following the acquisition of the product and related assets in August 2023[230] - The Safety Shot Beverage is formulated with 28 active ingredients and is manufactured in a facility adhering to Good Manufacturing Practices (GMP)[231][233] - The company plans to relaunch its Photocil product in the U.S. in Q4 2024 after receiving FDA approval, with current sales occurring in India through a licensing agreement[237] - Safety Shot Inc. is focusing on expanding its product line, including a powdered stick pack version of the Safety Shot Beverage, while discontinuing its CBD product offerings[234][239] - The Company is in commercialization mode while continuing to pursue the development of next-generation products and new products[277] Operational Efficiency - The weighted average number of common shares outstanding increased from 30.9 million in 2023 to 54.4 million in 2024, impacting the loss per share calculation[252] - The company maintains a diverse network of raw material suppliers, ensuring high-quality production for its beverage and other health products[238] - Safety Shot Inc. does not experience concentration risk or dependence on major customers, indicating a stable revenue generation strategy[237] - The company has not recognized any allowance for doubtful collections during the years ended December 31, 2024, and 2023, indicating effective receivables management[255] Financial Position - The deferred tax asset at December 31, 2024, was 14,660,582,fullyoffsetbyavaluationallowanceduetotheCompanyslackofearningshistory[259]Researchanddevelopmentexpensesamountedto14,660,582, fully offset by a valuation allowance due to the Company's lack of earnings history[259] - Research and development expenses amounted to 271,719 for the year ended December 31, 2024, compared to $100,591 for the year ended December 31, 2023[260] - The company aims to partner with industry leaders to access the latest technologies and expand its market reach[236]